• News

As FDA considers new Alzheimer’s drug, a case study details safety concerns

  • STAT
  • New York, NY
  • (January 04, 2023)

Sam Gandy, MD, PhD, discusses a new Alzheimer’s drug poised to be approved by U.S. regulators this week.

Learn more